Clinical Trial Update: The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Stable Angina

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: J.M. ten Berg | Conditions: Coronary Artery Disease, Stable Angina | Phase 3 | Status: UNKNOWN